Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with type 2 diabetes for a minimum of 6 months prior to Visit 1~* HbA1c at least 7.0 % - maximum 11 % at screening~* Subject is insulin naïve (short-term insulin treatment of up to 14 days is allowed)~* An antidiabetic regimen that has been stable for at least 3 months prior to screening~* An antidiabetic regimen that includes a minimum of 2 OADs~* OADs dosed at least 50% of the maximum recommended dose~Exclusion Criteria:~* Known or suspected hypersensitivity to trial product(s) or related products~* Females of childbearing potential who are pregnant, breast-feeding or intend to become pregnant or are not using adequate contraceptive methods (adequate contraceptive measures as required by local law or practice)~* The receipt of any investigational medicinal product within one month prior to this trial~* Suffer from a life threatening disease (cancer)~* Cardiac disease: class III or IV congestive heart failure (CHF), unstable angina, and or any myocardial infarction (treated or untreated) within 6 months prior to screening~* Hepatic insufficiency (Alanine aminotransferase (ALT) or Aspartate aminotransferase (AST) above 2 times the central laboratory's upper reference limit)~* Renal insufficiency (serum creatinine above 1.6 mg/dl for males; 1.4 mg/dl for females~* Recurrent hypoglycaemia or hypoglycaemic unawareness~* Anemia (haemoglobin below 10 mg/dl)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pre-breakfast BIAsp 30 (Type: EXPERIMENTAL): None
- Pre-dinner BIAsp 30 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).